Potential Treatment for Advanced Non-Small Cell Lung Cancers Before FDA for Approval
Lung Cancer, News
ARIAD Pharmaceuticals announced that it has completed the New Drug Application for brigatinib it filed with the U.S. Food and Drug Administration (FDA), seeking market approval to use the treatment in patients with metastatic ... Read more